COREVITAS registry 600+ PsA/SpA pts 7yrs follow-up TNFi ❗️Overall low persistency 39% at 2 yrs ❕TNFi persistency = across 6 disease domains ❗️Shorter treatment duration if Enthesitis or Ax PsA #ACR21 #Abst1818 @RheumNow https://t.co/1aE8eWn4TD